Top News arrow Safety Issues arrow Public Policy
Safety Issues - Public Policy
Marriage of Convenience: Mental Screening--Eli Lilly check $500k Print E-mail
Sunday, 05 March 2006

Mental Screening ties to drug companies exposed.  Screening for Mental Health (Harvard affiliated) received $500K from Eli Lillly. See:  http://ahrp.org/children/mentalscreen/LillyCheck.jpg

TeenScreen hired high powered PR firms whose business  is to  create promotional campaigns to increase drug sales for its clients.
Read more...
 
OHRP Response to AHRP Complaint & AHRP Reply Print E-mail
Friday, 03 March 2006
Did OHRP conduct an investigation of the PolyHeme blood experiment and did OHRP issue a report of its findings?
Read more...
 
FDA Approval process under fire--PML: Lethal side-effect--Tysabri: Multiple Sclerosis Drug Print E-mail
Friday, 03 March 2006
“When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease. Last year, she died at the age of 46 from an infection linked to the drug.”


Read more...
 
AHRP Files Federal Complaint Re: Non-Consensual "Blood Substitute" Experiment on Trauma Patients Print E-mail
Thursday, 02 March 2006
This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive.  PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood. 
Read more...
 
UK-MHRA Drug-Related Suicide Reports_Yellow Card Print E-mail
Wednesday, 01 March 2006
The UK adverse event drug reporting system utilizes the Yellow Card system for filing reports.
Read more...
 
More...
<< Start < Prev 61 62 63 64 65 66 67 68 69 70 Next > End >>

Results 613 - 621 of 753
[ Back ]
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]